Authorizes insurance policies which provide coverage for prescription drugs where cost-sharing obligations are determined by category of prescription drugs to offer a program to insureds that utilizes rebates or discounts to lower an insured's cost-sharing for prescription drugs if the insured's cost-sharing under such program would be more favorable than the cost-sharing that would otherwise be applicable to the prescription drug.
- Chamber
- House
- Introduced
- May 1, 2025
- Last action
- Jan 7, 2026 — REFERRED TO INSURANCE
- Session
- 2025-2026
- Momentum
- 27 · Low